Building resilience to regulatory risks
Future growth of Indian pharma companies hinge on their ability to successfully navigate regulatory inspections
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
API business
Alkem Laboratories brands API business as Alkem Activa
Alkem Activa plans to expand its capacity, incorporating technologies like biocatalytic and continuous manufacturing technologies
Sigachi Industries forays into API business, acquires majority stake in Trimax Bio Sciences
The API unit is approved by USFDA for advanced and critical intermediates
“China’s recovery will largely depend on how the world perceives China right now”
Suresh Pareek, Managing Director, Ideal Cures tells Viveka Roychowdhury that though their US expansion will be on hold currently…
Morepen Labs’ Net Profit rises by 256 per cent led by higher APIs exports
The company’s net sales revenue (standalone) in Q1 ’FY 2019-20 stood at Rs 186.70 crore showing a growth of 25.4 per cent…